Pin Wu

8PUBLICATIONS
28CO-AUTHORS
Haematological tumoursTissue engineeringMolecular targetsCancer cell biologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 04, 2026
PD-1 Inhibits CD4+ TRM-Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC.

Zheyu Shao, Qinyuan Liu, Zhongwei Xin

|Oct 28, 2025
Artificial Intelligence and Multimodality Data Integration Decipher Tertiary Lymphoid Structure Maturity in Gastric Cancer.

Wenxuan Wu, Zhenzhen Xun, Yaxuan Han

|Sep 18, 2024
Author Correction: Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans.

Lin Fan, Junwei Liu, Wei Hu

|Aug 12, 2024
Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLC.

Yongyuan Chen, Zheyu Shao, Zhixing Hao

|Jul 04, 2024
Hypoxia inhibits the iMo/cDC2/CD8+ TRMs immune axis in the tumor microenvironment of human esophageal cancer.

Chuanqiang Wu, Huan Yu, Fuxiang Liang

|Mar 16, 2024
Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans.

Lin Fan, Junwei Liu, Wei Hu

Pageof 2

Frequent Collaborators

3 joint publications

Ying Chai

2 joint publications

Wei Chen

1 joint publications

Zhongwei Xin

1 joint publications

Chuanqiang Wu